Publications

Click here for a complete list of Lidia Szczepaniak, PhD publications.


Selected Key Publications

Szczepaniak LS. Type 2 Diabetes: An unique approach . International Innovation: Lifting the Burden of Disease: Research Breakthroughs in Adult and Child Health (North America). 2013;121:65–67.

Sarma S, Carrick-Ranson G, Fujimoto N, Adams-Huet B, Bhella PS, Hastings JL, Shafer KM, Shibata S, Boyd K, Palmer D, Szczepaniak EW, Szczepaniak LS, Levine BD. Effects of age and aerobic fitness on myocardial lipid content. Circ Cardiovasc Imaging. 2013;6:1048–1055. doi:10.1161/.  Epub 2013 Sep 13.

Nelson, MD, Victor, RG, Szczepaniak EW, Garg A, Szczepaniak LS. Cardiac steatosis and lipotoxicity: A possible mechanism for cardiomyopathy in lipodystrophy. Am J Cardiol. 2013 Oct 1;112(7):1019–1024. doi:10.1016/j.amjcard.2013.05.036. Epub 2013 Jun 22.

Price AL, Lingvay  I, Szczepaniak EW, Wiebel  J, Victor RG, Szczepaniak LS. The metabolic cost of lowering blood pressure with hydrochlorothiazide. Diabetology & Metabolic Syndrome. 2013;(5)35. doi:10.1186/1758-5996-5-35.

Szczepaniak EW, Malliaras K, Nelson MD, Szczepaniak LS, Measurement of pancreatic volume by abdominal MRI: A validation study. PLOS One. 2013;8(2):e55991. doi:10.1371/journal.pone.0055991. Epub 2013 Feb 13.

Szczepaniak LS, Victor RG, Mathur R,  Nelson MD, Szczepaniak EW, Tyer N, Chen I, Unger RH, Bergman RN, Lingvay I. Pancreatic steatosis and its relationship to b-cell dysfunction in humans: Racial and ethnic variations. Diabetes Care. 2012;35(11):2377–2383. doi:10.2337/dc12-0701. Epub 2012 Sep 11.

Lingvay I, Roe ED, Duong J, Leonard D, Szczepaniak LS. Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes. J Investig Med. 2012 Oct;60(7):1059–1063.

McGavock J, Szczepaniak LS, Ayers CR, Abdullah SM, See R, Gore MO, Drazner MH, de Lemos JA, McGuire DK. The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial. Diab Vasc Dis Res. 2012 Apr;9(2):131–137.

Lee Y, Lingvay I, Szczepaniak LS, Ravazzola M, Orci L, Unger RH. Pancreatic steatosis: Harbinger of type 2 diabetes in obese rodents. Int J Obes (London). 2010;34(2):396–400.

Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B, Zhang S, Unger RH, Szczepaniak LS. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab. 2009;94(10):4070–4076.

Lingvay I, Raskin P, Szczepaniak LS. The fatty hearts of patients with diabetes. Nat Rev Cardiol. 2009;6(4):268–269.

Abel ED, Kelly D, Devereux R, Hollander J, Kajstura J, Losordo D, Peterson L, Schaffer J, Stanley W, Sturek M, Szczepaniak L, Taegtmeyer H, Dillmann W, Young L., NHLBI Working Group. Interdisciplinary approaches to diabetic heart disease: Mechanisms, prevention, early detection and therapeutic target: Executive summary. 2009;NHLBI Strategic Plan Goals 1 & 2.

Zib I, Jacob AN, Lingvay I, Salinas K, McGavock JM, Raskin P, Szczepaniak LS. Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes. J Investig Med. 2007;55(5):230–236.

Vega GL, Chandalia M, Szczepaniak LS, Grundy SM. Metabolic correlates of nonalcoholic fatty liver in women and men. Hepatology. 2007;46(3):716–722.

Lingvay I, Raskin P, Szczepaniak LS. Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes. J Diabetes Complications. 2007;21:137–142.

Szczepaniak LS, Victor RG, Orci L, Unger RH. Forgotten but not gone: The rediscovery of fatty heart, America’s most common unrecognized disease. Circ Res. 2007;101(8):759–767.

McGavock JM, Victor RG, Unger RH, Szczepaniak LS. Adiposity of the heart: Revisited. Ann Intern Med. 2006;144:517–524.

Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS. Determination of triglyceride in the human myocardium using magnetic resonance spectroscopy: Reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab. 2005;289(5):E935–939.

Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288(2):E462–468.

Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology. 2004;40(6):1387–1395.

Dobbins RL, Szczepaniak LS, Zhang W, McGarry JD. Chemical sympathectomy alters regulation of body weight during prolonged ICV leptin infusion. Am J Physiol Endocrinol Metab. 2003;284(4):E778–787.

Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D’Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG. Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med. 2003;49(3):417–423.

Simha V, Szczepaniak LS, Wagner AJ, DePaoli AM, Garg A. Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. Diabetes Care. 2003;26(1):30–35.

Nurenberg P, Sartoni-D’Ambrosia G, Szczepaniak LS. Magnetic resonance spectroscopy of renal and other retroperitoneal tumors. Curr Opin Urol. 2002;12(5):375–380.

Szczepaniak LS, Dobbins RL, Stein DT, McGarry JD. Bulk magnetic susceptibility effects on the assessment of intra- and extra-myocellular lipids in vivo. Magn Reson Med. 2002;47(3):607–610.

Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT. Measurement of intracellular triglyceride stores by H spectroscopy: Validation in vivo. Am J Physiol. 1999;276(5,pt1):E977–989.